Cancer Genetics Q3 Sales $2.07M Up From $535K YoY

Cancer Genetics (NASDAQ:CGIX) reported $2.07 million in sales this quarter. This is a 286.92 percent increase over sales of $535 thousand the same period last year.

Benzinga · 11/20/2019 13:03

Cancer Genetics (NASDAQ:CGIX) reported $2.07 million in sales this quarter. This is a 286.92 percent increase over sales of $535 thousand the same period last year.